Investigating apolipoproteins of human high-density lipoprotein by cyclodextrin-micellar electrokinetic chromatography

被引:2
作者
Hsu, Yun-Hsun [1 ]
Toh, Jia-Jia [1 ]
Chang, Chiz-Tzung [2 ]
Liu, Mine-Yine [1 ]
机构
[1] Natl Changhua Univ Educ, Dept Chem, Changhua 50058, Taiwan
[2] China Med Univ, Coll Med, Taichung, Taiwan
关键词
Apolipoproteins; HDL; CD-MEKC; Bile salts; Carboxymethyl-beta-cyclodextrin; REVERSE CHOLESTEROL TRANSPORT; AMINO-ACID-SEQUENCE; A-II; CAPILLARY-ELECTROPHORESIS; CARDIOVASCULAR-DISEASE; HDL COMPOSITION; HUMAN PLASMA; APOA-I; C-III; INFLAMMATION;
D O I
10.1016/j.chroma.2019.01.073
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A cyclodextrin-micellar electrokinetic chromatography (CD-MEKC) method has been developed to determine the apolipoproteins (apos) of human high-density lipoprotein (HDL). The optimal CD-MEKC conditions included a separation buffer mixture of 5 mM sodium phosphate, 40 mM bile salts (50% sodium cholate and 50% sodium deoxycholate), 25 mM carboxymethyl-beta-CD (CM-beta-CD) and pH 7.0. The separation voltage was 15 kV, and the capillary temperature was 15 degrees. The CD-MEKC profiles of human HDL apolipoproteins showed good repeatability and sensitivity. Linear analysis has been performed for human apolipoprotein standards including apos AI, AII, CI, CII, CIII and E. Linear regression lines with coefficients of determination (R-2) greater than 0.99 were obtained for apos AI, AII, CI, CII and E. The linear ranges for the six apolipoproteins were within 0.18-0.70 mg/mL, and the concentration limits of detection (LOD) were lower than 0.0617 mg/mL. Apos AI, AII, CI and CIII were identified and quantified in human HDL by comparing with apolipoprotein standards. Furthermore, the CD-MEKC profiles of uremic patients differed significantly from healthy subjects. The concentration ratios of apo AI/apo CIII were significantly lower for uremic patients than healthy subjects. This study demonstrated the feasibility of determining human HDL apolipoproteins by CD-MEKC. In the future, it might help monitor the progression of uremia and cardiovascular disease. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 173
页数:10
相关论文
共 50 条
  • [21] Preparation and Activity Analysis of Recombinant Human High-Density Lipoprotein
    Su, Manman
    Chang, Weiqin
    Shi, Kaiyao
    Wang, Dingding
    Wang, Mingxing
    Xu, Tianmin
    Yan, Weiqun
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2012, 10 (05) : 485 - 491
  • [22] Speciated Human High-Density Lipoprotein Protein Proximity Profiles
    Gauthamadasa, Kekulawalage
    Rosales, Corina
    Pownall, Henry J.
    Macha, Stephen
    Jerome, W. Gray
    Huang, Rong
    Silva, R. A. Gangani D.
    BIOCHEMISTRY, 2010, 49 (50) : 10656 - 10665
  • [23] Chiral separation of raltitrexed by cyclodextrin-modified micellar electrokinetic chromatography
    Liu, Yi
    Fu, Xiaofang
    Ma, Chao
    Zhong, Jiasheng
    Liao, Yiping
    Liu, Huwei
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 393 (01) : 321 - 326
  • [24] Separation of phthalates by cyclodextrin modified micellar electrokinetic chromatography: Quantitation in perfumes
    Perez-Fernandez, Virginia
    Jose Gonzalez, Maria
    Angeles Garcia, Maria
    Luisa Marina, Maria
    ANALYTICA CHIMICA ACTA, 2013, 782 : 67 - 74
  • [25] HIGH-DENSITY-LIPOPROTEIN SUBFRACTIONS, APOLIPOPROTEINS AND ANTIPYRINE CLEARANCE IN NORMAL SUBJECTS
    LUOMA, PV
    RAUTIO, A
    STENGARD, J
    SOTANIEMI, EA
    MARNIEMI, J
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (06) : 625 - 627
  • [26] High-density Lipoprotein (HDL) Dysfunction and the Future of HDL
    Ertek, Sibel
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (05) : 490 - 498
  • [27] High-Density Lipoprotein: Is the Good Cholesterol Turning Bad?
    Inankur A.
    Nicholls S.J.
    Jahangiri A.
    Current Cardiovascular Risk Reports, 2011, 5 (1) : 18 - 28
  • [28] High-density lipoprotein: Multipotent effects on cells of the vasculature
    Cockerill, GW
    Reed, S
    INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 188, 1999, 188 : 257 - 297
  • [29] High-density lipoprotein carbamylation and dysfunction in vascular disease
    Santana, Jeans M.
    Brown, Clinton D.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2018, 23 : 2227 - 2234
  • [30] The paradox of dysfunctional high-density lipoprotein
    Ansell, Benjamin J.
    Fonarow, Gregg C.
    Fogelman, Alan M.
    CURRENT OPINION IN LIPIDOLOGY, 2007, 18 (04) : 427 - 434